Uqh 1,4-bis-hemi-succinate
Uqh 1,4-bis-hemi-succinate has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Sep 1, 2026: “Enhanced Extracellular Matrix Synthesis-Related Responses Induced by Ubiquinol-10 Derivatives in Human Dermal Fibroblasts”.
1 paper studies it2 findingsUpdated
See all 1 papers on uqh 1,4-bis-hemi-succinate
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Fukuoka University
- Cells1
What did studies of uqh 1,4-bis-hemi-succinate find?
2Studies of uqh 1,4-bis-hemi-succinate measured 2 outcomes: COL1A1 and senescence-associated secretory phenotype (SASP).
COL1A1
upin human cells1
1 study
COL1A1
upin human cells1
Uqh 1,4-bis-hemi-succinate increases COL1A1 in NHDFs.
“upregulated ECM components including COL1A1, elastin, and hyaluronic acid”
Cellsin NHDFsdermis100 μM48 h
BioFactors (Oxford, England)
Senescence-associated secretory phenotype (SASP)
downin human cells1
1 study
Senescence-associated secretory phenotype (SASP)
downin human cells1
Uqh 1,4-bis-hemi-succinate decreases senescence-associated secretory phenotype (SASP) in NHDFs.
“suppressed SASP factors, and upregulated ECM components including COL1A1, elastin, and hyaluronic acid”
Cellsin NHDFsdermis100 μM48 h
BioFactors (Oxford, England)